DUSA Pharmaceuticals (DUSA) Tops Q1 EPS by 1c

DUSA Pharmaceuticals (NASDAQ: DUSA) reported Q1 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $13.4 million versus the consensus estimate of $12.92 million.

For earnings history and earnings-related data on DUSA Pharmaceuticals (DUSA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance